Bitcoin's recovery is challenged by rising long-term U.S. Treasury yields after the Federal Reserve raised interest rates by 25 basis points to a 3.75%-4% range and the Senate narrowly rejected advancing the CLARITY Act. Ten- and 30-year Treasury yields increased sharply, making interest-bearing assets more attractive compared to Bitcoin, which offers no yield. Analysts note that while buying interest in Bitcoin continues, it has diminished as yields rise, highlighting the complex impact of bond market movements versus scheduled Fed decisions. The recent yield increase may slow Bitcoin's recovery but has not yet reversed it.
Bitcoin's recovery amid rising U.S. Treasury yields is presented here with Pluang's cryptocurrency market data for context. For readers following cryptocurrency markets, as of Sep 29, 2026 03:53 WIB, breadth showed 10 out of 50 major cryptocurrencies rose while 39 fell. Notable movers include BAL with a 1-day change of +11.14%, COTI down -12.73%, and UNI down -9.99%.
Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...
Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...
Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...
A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...
Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...
